Article
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China.
Tumori - 1 Jun 2023
Li Hui, Li Xiang, Lan Shaowei, Zuo Xuerong, Du Tianying, Liu Ying, Zhang Caixia, Zhu Jing, Cheng Ying
Abstract excerpt
OBJECTIVE: This study aimed to explore erb-b2 receptor tyrosine kinase 2 (ERBB2) gene mutations in patients with non-small cell lung cancers (NSCLC) in Northeast China, and to analyze ERBB2 mutation subtypes and clinicopathological characteristics related to the presence of ERBB2 mutations. METHODS: In this study, 1087 tissue samples, 368 whole blood samples, and 68 pleural effusion samples from 1349 NSCLC were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
